Harvard Bioscience Inc (FRA:HBI0)

Q1 2026 Harvard Bioscience Inc Earnings Call Transcript

May 12, 2026 / 12:00 PM GMT

Release Date Price: €4.08

Transcript 10-Q8-K

Key Points

Positve

Harvard Bioscience Inc (HBIO) reported Q1 revenue of $20.8 million, aligning with their expectations.
Adjusted gross margin improved to 59%, a growth of nearly 300 basis points year-over-year.
Sales of new product innovations like MESH MEA, BTX, and SOHO telemetry products drove growth, with expectations of double-digit revenue growth for the full year.
Sales to pharma and large biotech customers grew more than 20% in the quarter compared to the previous year.
The company is on track with Project Viking, a manufacturing consolidation initiative, expected to generate significant savings in the coming years.

Negative

Revenue was slightly below the $21.8 million reported in Q1 2025, primarily due to lower sales from academic institutions in the Americas and distributors in APAC.
Operating loss was $1.2 million, although significantly improved from a loss of $49.7 million last year due to goodwill impairment.
Adjusted EBITDA was flat year-over-year and slightly below expectations due to higher investment in sales and marketing activities.
Cash used in operations was $0.7 million, compared to cash generation of $3 million in the same quarter last year, due to higher inventory levels.
Net debt increased by approximately $1.9 million from the prior year due to deferred finance costs related to a debt deal.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HBIO.OQ - Harvard Bioscience Inc
Q1 2026 Harvard Bioscience Inc Earnings Call
May 12, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and welcome to the Q1 2026 Harvard Biosciences Inc. Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question, you will need to press *11 on your touch tone telephone. Please note this call is being recorded.

I would like to turn the call over to Taylor Krafchick, Senior Vice President at ELISA's TA. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good morning, everyone.

Thank you for

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.